Walker Neal — SEC Form 4 filings
SEC reporting owner CIK 1604457. 24 Form 4 filings on record with FilingPulse; latest filed 2026-06-11.
Transaction summary — filings shown
Covers all 24 filings on record, filed 2024-02-05 to 2026-06-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 72.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | CEO, Director | 21 | — | — | 66 |
| Aldeyra Therapeutics, Inc. (ALDX) | Director | 3 | — | — | 6 |
Form 4 filings — Walker Neal
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-11 | 4 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/award (A): 70,000 (derivative) @ $0 · Grant/award (A): 3,318 (derivative) @ $0 | EDGAR |
| 2026-02-06 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Grant/award (A): 274,800 (derivative) @ $0 · Grant/award (A): 961,700 (derivative) @ $0 | EDGAR |
| 2026-02-05 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 63,475 · Tax withholding (F): 18,611 @ $3.47 · Option exercise (M): 63,475 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 29,150 · Tax withholding (F): 9,952 @ $2.88 · Option exercise (M): 29,150 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/award (A): 62,728 (derivative) @ $0 · Grant/award (A): 2,413 (derivative) @ $0 | EDGAR |
| 2025-05-05 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 9,467 · Tax withholding (F): 2,975 @ $1.38 · Option exercise (M): 9,467 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 9,467 · Tax withholding (F): 3,042 @ $1.48 · Option exercise (M): 9,467 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 9,466 · Tax withholding (F): 3,277 @ $1.99 · Option exercise (M): 9,466 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 9,467 · Tax withholding (F): 3,559 @ $2.48 · Option exercise (M): 9,467 (derivative) @ $0 · Grant/award (A): 253,900 (derivative) @ $0 · Grant/award (A): 888,800 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 9,467 · Tax withholding (F): 3,904 @ $2.48 · Option exercise (M): 29,149 · Tax withholding (F): 13,532 @ $2.48 · Option exercise (M): 9,467 (derivative) @ $0 · Grant/award (A): 88,333 (derivative) @ $0 · +1 more | EDGAR |
| 2024-12-06 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 118,840 @ $1.52 · Tax withholding (F): 68,343 @ $3.76 · Option exercise (M): 118,840 (derivative) @ $0 | EDGAR |
| 2024-12-03 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 9,466 · Tax withholding (F): 2,721 @ $4.07 · Option exercise (M): 9,466 (derivative) @ $0 | EDGAR |
| 2024-11-05 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 9,467 · Tax withholding (F): 2,721 @ $2.09 · Option exercise (M): 9,467 (derivative) @ $0 | EDGAR |
| 2024-10-03 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 9,467 · Tax withholding (F): 2,722 @ $1.18 · Option exercise (M): 9,467 (derivative) @ $0 | EDGAR |
| 2024-09-04 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 9,466 · Tax withholding (F): 2,722 @ $1.18 · Option exercise (M): 9,466 (derivative) @ $0 | EDGAR |
| 2024-08-13 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 43,548 @ $0.72 · Option exercise (M): 43,548 (derivative) @ $0 | EDGAR |
| 2024-08-05 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 9,467 · Tax withholding (F): 2,722 @ $1.32 · Option exercise (M): 9,467 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 9,467 · Tax withholding (F): 2,722 @ $1.15 · Option exercise (M): 9,467 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/award (A): 40,282 (derivative) @ $0 · Grant/award (A): 1,736 (derivative) @ $0 | EDGAR |
| 2024-06-04 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 9,466 · Tax withholding (F): 2,722 @ $1.03 · Option exercise (M): 9,466 (derivative) @ $0 | EDGAR |
| 2024-05-03 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 9,467 · Tax withholding (F): 2,784 @ $1.26 · Option exercise (M): 9,467 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 9,467 · Tax withholding (F): 3,224 @ $1.26 · Option exercise (M): 9,467 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 9,466 · Tax withholding (F): 3,223 @ $1.24 · Option exercise (M): 9,466 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Grant/award (A): 497,000 (derivative) @ $0 · Grant/award (A): 142,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1604457 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →